Results 31 to 40 of about 21,989 (186)

Comparison of Interferon‐Gamma Release Assay and Tuberculin Skin Test for the Screening of Latent Tuberculosis in Inflammatory Bowel Disease Patients: Indian Scenario

open access: yesTuberculosis Research and Treatment, Volume 2021, Issue 1, 2021., 2021
Background. In a country like India, where the prevalence of tuberculosis is very high, the role of screening tools for detection of latent tuberculosis infection (LTBI) like TST and IGRA is still unclear, especially in inflammatory bowel disease (IBD) patients.
Alok Kumar Mantri   +8 more
wiley   +1 more source

Flow of LTBI patient evaluation and testing at BCHD in the post-QFT-GIT period. [PDF]

open access: yes, 2012
*Among 750 referrals, 690 had a TST by referring source, 23 had a QFT-GIT by the referring source, and 5 had both a QFT-GIT and TST performed by referral source); 32 individuals were referred as B-Waivers without prior LTBI testing based on abnormal CXR ...
Susan E. Dorman (143301)   +6 more
core   +1 more source

Differences in LTBI diagnosis among referrals to BCHD between study periods and by QFT-GIT test status. [PDF]

open access: yes, 2012
*includes individuals that had QFT-GIT performed by referral source. 11/399 individuals in the post-QFT-GIT period had QFT-GIT drawn but no results available; there was 1 indeterminate result in the post-QFT-GIT-period ...
Susan E. Dorman (143301)   +6 more
core   +1 more source

Comparison of the Sensitivity of QuantiFERON-TB Gold In-Tube and T-SPOT.TB According to Patient Age. [PDF]

open access: yesPLoS ONE, 2016
Currently, there are two types of interferon-gamma release assays (IGRAs) in use for the detection of tuberculosis (TB) infection, the QuantiFERON-TB Gold In-Tube test (GFT-GIT) and T-SPOT.TB.
Won Bae   +10 more
doaj   +1 more source

Age-specific agreement of TST and QFT-GIT assays. [PDF]

open access: yes, 2018
Age-specific agreement of TST and QFT-GIT assays.
Nikhil Gupte (189999)   +20 more
core   +1 more source

Comparison of the change in QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube results after preventive therapy for latent tuberculosis infection.

open access: yesPLoS ONE, 2020
BackgroundWe investigated changes in the interferon-γ levels before and after treatment of latent tuberculosis infection (LTBI) using QuantiFERON-TB Gold Plus (QFT-Plus) and QuantiFERON-TB Gold In-Tube (QFT-GIT) assays.
Ock-Hwa Kim   +6 more
doaj   +1 more source

Diagnostic values of the QuantiFERON-TB Gold In-tube assay carried out in China for diagnosing pulmonary tuberculosis. [PDF]

open access: yesPLoS ONE, 2015
BACKGROUND:Interferon-release assays (IGRAs) for diagnosing active pulmonary tuberculosis (PTB) are not yet fully validated, particularly in high TB-endemic areas as the People's Republic of China (PRC).
Hui Xia   +7 more
doaj   +1 more source

Diagnostic usefulness of the QuantiFERON-TB gold in-tube test (QFT-GIT) for tuberculous vertebral osteomyelitis

open access: yesInfectious Diseases, 2017
Background: Interferon (IFN)-γ-releasing assay for diagnosing tuberculosis (TB) has shown promise; however, there are only a few reports on usefulness of the QuantiFERON-TB Gold In-Tube test (QFT-GIT) for diagnosing TB vertebral osteomyelitis. Methods: All patients presenting at a tertiary hospital between January 2010 and July 2016 with suspected TB ...
Sungim Choi   +13 more
openaire   +2 more sources

Factors associated with positive TST and /or QFT-GIT assays. [PDF]

open access: yes, 2018
Factors associated with positive TST and /or QFT-GIT assays.
Nikhil Gupte (189999)   +20 more
core   +1 more source

Monocyte-to-lymphocyte ratio is significantly associated with positive QuantiFERON-TB Gold-In-Tube and adult survival: an observational study

open access: yesScientific Reports, 2022
This study aimed to find significant factors associated with tuberculosis (TB) infection and disease development. The participants were from National Health and Nutrition Examination Survey (NHANES) and National Death Index (NDI).
Hai-bo Hua, Hui-jie Wang
doaj   +1 more source

Home - About - Disclaimer - Privacy